1. Home
  2. Pharma & Healthcare
  3. Global Ophthalmic Therapeutics/Drug Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Global Ophthalmic Therapeutics/Drug Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Publication Month: Feb 2020 | No. of Pages: 102 Published By: Global Info Research
Single User License: US $ 3480
Corporate User License: US $ 6960

Market Overview
The global Ophthalmic Therapeutics/Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Ophthalmic Therapeutics/Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Ophthalmic Therapeutics/Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Ophthalmic Therapeutics/Drug market has been segmented into:
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Others

By Application, Ophthalmic Therapeutics/Drug has been segmented into:
Dry Eye
Allergies
Glaucoma
Infection
Retinal Disorders
Uveitis
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Ophthalmic Therapeutics/Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Ophthalmic Therapeutics/Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Ophthalmic Therapeutics/Drug market.

The report offers in-depth assessment of the growth and other aspects of the Ophthalmic Therapeutics/Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Ophthalmic Therapeutics/Drug Market Share Analysis
Ophthalmic Therapeutics/Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Ophthalmic Therapeutics/Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Ophthalmic Therapeutics/Drug sales, revenue and market share for each player covered in this report.

The major players covered in Ophthalmic Therapeutics/Drug are:
Alcon
Pfizer Inc.
Novartis AG
Johnson and Johnson Vision Care, Inc.
Allergan
Bausch & Lomb Incorporated
Bayer AG
Regeneron Pharmaceuticals Inc.
Merck Sharp & Dohme Corp.
Valeant
Santen Pharmaceuticals Co. Ltd
Genentech, Inc.

Table of Contents

1 Ophthalmic Therapeutics/Drug Market Overview
1.1 Product Overview and Scope of Ophthalmic Therapeutics/Drug
1.2 Classification of Ophthalmic Therapeutics/Drug by Type
1.2.1 Global Ophthalmic Therapeutics/Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Ophthalmic Therapeutics/Drug Revenue Market Share by Type in 2019
1.2.3 Anti-allergy
1.2.4 Anti-VEGF Agents
1.2.5 Anti-inflammatory
1.2.6 Anti-glaucoma
1.2.7 Others
1.3 Global Ophthalmic Therapeutics/Drug Market by Application
1.3.1 Overview: Global Ophthalmic Therapeutics/Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Dry Eye
1.3.3 Allergies
1.3.4 Glaucoma
1.3.5 Infection
1.3.6 Retinal Disorders
1.3.7 Uveitis
1.3.8 Others
1.4 Global Ophthalmic Therapeutics/Drug Market by Regions
1.4.1 Global Ophthalmic Therapeutics/Drug Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Ophthalmic Therapeutics/Drug (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Ophthalmic Therapeutics/Drug Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Ophthalmic Therapeutics/Drug Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Ophthalmic Therapeutics/Drug Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Ophthalmic Therapeutics/Drug Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Ophthalmic Therapeutics/Drug Status and Prospect (2015-2025)
2 Company Profiles
2.1 Alcon
2.1.1 Alcon Details
2.1.2 Alcon Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Alcon SWOT Analysis
2.1.4 Alcon Product and Services
2.1.5 Alcon Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer Inc.
2.2.1 Pfizer Inc. Details
2.2.2 Pfizer Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer Inc. SWOT Analysis
2.2.4 Pfizer Inc. Product and Services
2.2.5 Pfizer Inc. Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis AG SWOT Analysis
2.3.4 Novartis AG Product and Services
2.3.5 Novartis AG Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson and Johnson Vision Care, Inc.
2.4.1 Johnson and Johnson Vision Care, Inc. Details
2.4.2 Johnson and Johnson Vision Care, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson and Johnson Vision Care, Inc. SWOT Analysis
2.4.4 Johnson and Johnson Vision Care, Inc. Product and Services
2.4.5 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2018-2019)
2.5 Allergan
2.5.1 Allergan Details
2.5.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Allergan SWOT Analysis
2.5.4 Allergan Product and Services
2.5.5 Allergan Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bausch & Lomb Incorporated
2.6.1 Bausch & Lomb Incorporated Details
2.6.2 Bausch & Lomb Incorporated Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bausch & Lomb Incorporated SWOT Analysis
2.6.4 Bausch & Lomb Incorporated Product and Services
2.6.5 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bayer AG
2.7.1 Bayer AG Details
2.7.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bayer AG SWOT Analysis
2.7.4 Bayer AG Product and Services
2.7.5 Bayer AG Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2018-2019)
2.8 Regeneron Pharmaceuticals Inc.
2.8.1 Regeneron Pharmaceuticals Inc. Details
2.8.2 Regeneron Pharmaceuticals Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Regeneron Pharmaceuticals Inc. SWOT Analysis
2.8.4 Regeneron Pharmaceuticals Inc. Product and Services
2.8.5 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2018-2019)
2.9 Merck Sharp & Dohme Corp.
2.9.1 Merck Sharp & Dohme Corp. Details
2.9.2 Merck Sharp & Dohme Corp. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Merck Sharp & Dohme Corp. SWOT Analysis
2.9.4 Merck Sharp & Dohme Corp. Product and Services
2.9.5 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2018-2019)
2.10 Valeant
2.10.1 Valeant Details
2.10.2 Valeant Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Valeant SWOT Analysis
2.10.4 Valeant Product and Services
2.10.5 Valeant Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2018-2019)
2.11 Santen Pharmaceuticals Co. Ltd
2.11.1 Santen Pharmaceuticals Co. Ltd Details
2.11.2 Santen Pharmaceuticals Co. Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Santen Pharmaceuticals Co. Ltd SWOT Analysis
2.11.4 Santen Pharmaceuticals Co. Ltd Product and Services
2.11.5 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2018-2019)
2.12 Genentech, Inc.
2.12.1 Genentech, Inc. Details
2.12.2 Genentech, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Genentech, Inc. SWOT Analysis
2.12.4 Genentech, Inc. Product and Services
2.12.5 Genentech, Inc. Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Ophthalmic Therapeutics/Drug Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Ophthalmic Therapeutics/Drug Players Market Share
3.2.2 Top 10 Ophthalmic Therapeutics/Drug Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Ophthalmic Therapeutics/Drug Revenue and Market Share by Regions
4.2 North America Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
4.3 Europe Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
4.5 South America Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
5 North America Ophthalmic Therapeutics/Drug Revenue by Countries
5.1 North America Ophthalmic Therapeutics/Drug Revenue by Countries (2015-2020)
5.2 USA Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
5.3 Canada Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
5.4 Mexico Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
6 Europe Ophthalmic Therapeutics/Drug Revenue by Countries
6.1 Europe Ophthalmic Therapeutics/Drug Revenue by Countries (2015-2020)
6.2 Germany Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
6.3 UK Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
6.4 France Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
6.5 Russia Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
6.6 Italy Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Ophthalmic Therapeutics/Drug Revenue by Countries
7.1 Asia-Pacific Ophthalmic Therapeutics/Drug Revenue by Countries (2015-2020)
7.2 China Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
7.3 Japan Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
7.4 Korea Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
7.5 India Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
8 South America Ophthalmic Therapeutics/Drug Revenue by Countries
8.1 South America Ophthalmic Therapeutics/Drug Revenue by Countries (2015-2020)
8.2 Brazil Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
8.3 Argentina Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Ophthalmic Therapeutics/Drug by Countries
9.1 Middle East & Africa Ophthalmic Therapeutics/Drug Revenue by Countries (2015-2020)
9.2 Saudi Arabia Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
9.3 UAE Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
9.4 Egypt Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
9.5 South Africa Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Ophthalmic Therapeutics/Drug Revenue and Market Share by Type (2015-2020)
10.2 Global Ophthalmic Therapeutics/Drug Market Forecast by Type (2019-2024)
10.3 Anti-allergy Revenue Growth Rate (2015-2025)
10.4 Anti-VEGF Agents Revenue Growth Rate (2015-2025)
10.5 Anti-inflammatory Revenue Growth Rate (2015-2025)
10.6 Anti-glaucoma Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Ophthalmic Therapeutics/Drug Market Segment by Application
11.1 Global Ophthalmic Therapeutics/Drug Revenue Market Share by Application (2015-2020)
11.2 Ophthalmic Therapeutics/Drug Market Forecast by Application (2019-2024)
11.3 Dry Eye Revenue Growth (2015-2020)
11.4 Allergies Revenue Growth (2015-2020)
11.5 Glaucoma Revenue Growth (2015-2020)
11.6 Infection Revenue Growth (2015-2020)
11.7 Retinal Disorders Revenue Growth (2015-2020)
11.8 Uveitis Revenue Growth (2015-2020)
11.9 Others Revenue Growth (2015-2020)
12 Global Ophthalmic Therapeutics/Drug Market Size Forecast (2021-2025)
12.1 Global Ophthalmic Therapeutics/Drug Market Size Forecast (2021-2025)
12.2 Global Ophthalmic Therapeutics/Drug Market Forecast by Regions (2021-2025)
12.3 North America Ophthalmic Therapeutics/Drug Revenue Market Forecast (2021-2025)
12.4 Europe Ophthalmic Therapeutics/Drug Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Ophthalmic Therapeutics/Drug Revenue Market Forecast (2021-2025)
12.6 South America Ophthalmic Therapeutics/Drug Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Ophthalmic Therapeutics/Drug Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

Tables and Figures

List of Tables

Table 1. Global Ophthalmic Therapeutics/Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Ophthalmic Therapeutics/Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Ophthalmic Therapeutics/Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Ophthalmic Therapeutics/Drug Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Alcon Corporate Information, Location and Competitors
Table 6. Alcon Ophthalmic Therapeutics/Drug Major Business
Table 7. Alcon Ophthalmic Therapeutics/Drug Total Revenue (USD Million) (2017-2018)
Table 8. Alcon SWOT Analysis
Table 9. Alcon Ophthalmic Therapeutics/Drug Product and Solutions
Table 10. Alcon Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Pfizer Inc. Corporate Information, Location and Competitors
Table 12. Pfizer Inc. Ophthalmic Therapeutics/Drug Major Business
Table 13. Pfizer Inc. Ophthalmic Therapeutics/Drug Total Revenue (USD Million) (2018-2019)
Table 14. Pfizer Inc. SWOT Analysis
Table 15. Pfizer Inc. Ophthalmic Therapeutics/Drug Product and Solutions
Table 16. Pfizer Inc. Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Novartis AG Corporate Information, Location and Competitors
Table 18. Novartis AG Ophthalmic Therapeutics/Drug Major Business
Table 19. Novartis AG Ophthalmic Therapeutics/Drug Total Revenue (USD Million) (2017-2018)
Table 20. Novartis AG SWOT Analysis
Table 21. Novartis AG Ophthalmic Therapeutics/Drug Product and Solutions
Table 22. Novartis AG Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Johnson and Johnson Vision Care, Inc. Corporate Information, Location and Competitors
Table 24. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Major Business
Table 25. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Total Revenue (USD Million) (2017-2018)
Table 26. Johnson and Johnson Vision Care, Inc. SWOT Analysis
Table 27. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Product and Solutions
Table 28. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Allergan Corporate Information, Location and Competitors
Table 30. Allergan Ophthalmic Therapeutics/Drug Major Business
Table 31. Allergan Ophthalmic Therapeutics/Drug Total Revenue (USD Million) (2017-2018)
Table 32. Allergan SWOT Analysis
Table 33. Allergan Ophthalmic Therapeutics/Drug Product and Solutions
Table 34. Allergan Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bausch & Lomb Incorporated Corporate Information, Location and Competitors
Table 36. Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Major Business
Table 37. Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Total Revenue (USD Million) (2017-2018)
Table 38. Bausch & Lomb Incorporated SWOT Analysis
Table 39. Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Product and Solutions
Table 40. Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Bayer AG Corporate Information, Location and Competitors
Table 42. Bayer AG Ophthalmic Therapeutics/Drug Major Business
Table 43. Bayer AG Ophthalmic Therapeutics/Drug Total Revenue (USD Million) (2017-2018)
Table 44. Bayer AG SWOT Analysis
Table 45. Bayer AG Ophthalmic Therapeutics/Drug Product and Solutions
Table 46. Bayer AG Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Regeneron Pharmaceuticals Inc. Corporate Information, Location and Competitors
Table 48. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Major Business
Table 49. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Total Revenue (USD Million) (2017-2018)
Table 50. Regeneron Pharmaceuticals Inc. SWOT Analysis
Table 51. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Product and Solutions
Table 52. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Merck Sharp & Dohme Corp. Corporate Information, Location and Competitors
Table 54. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Major Business
Table 55. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Total Revenue (USD Million) (2017-2018)
Table 56. Merck Sharp & Dohme Corp. SWOT Analysis
Table 57. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Product and Solutions
Table 58. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Valeant Corporate Information, Location and Competitors
Table 60. Valeant Ophthalmic Therapeutics/Drug Major Business
Table 61. Valeant Ophthalmic Therapeutics/Drug Total Revenue (USD Million) (2017-2018)
Table 62. Valeant SWOT Analysis
Table 63. Valeant Ophthalmic Therapeutics/Drug Product and Solutions
Table 64. Valeant Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Santen Pharmaceuticals Co. Ltd Corporate Information, Location and Competitors
Table 66. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Major Business
Table 67. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Total Revenue (USD Million) (2017-2018)
Table 68. Santen Pharmaceuticals Co. Ltd SWOT Analysis
Table 69. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Product and Solutions
Table 70. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Genentech, Inc. Corporate Information, Location and Competitors
Table 72. Genentech, Inc. Ophthalmic Therapeutics/Drug Major Business
Table 73. Genentech, Inc. Ophthalmic Therapeutics/Drug Total Revenue (USD Million) (2017-2018)
Table 74. Genentech, Inc. SWOT Analysis
Table 75. Genentech, Inc. Ophthalmic Therapeutics/Drug Product and Solutions
Table 76. Genentech, Inc. Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Ophthalmic Therapeutics/Drug Revenue (Million USD) by Players (2015-2020)
Table 78. Global Ophthalmic Therapeutics/Drug Revenue Share by Players (2015-2020)
Table 79. Global Ophthalmic Therapeutics/Drug Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Regions (2015-2020)
Table 81. North America Ophthalmic Therapeutics/Drug Revenue by Countries (2015-2020)
Table 82. North America Ophthalmic Therapeutics/Drug Revenue Market Share by Countries (2015-2020)
Table 83. Europe Ophthalmic Therapeutics/Drug Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Ophthalmic Therapeutics/Drug Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Ophthalmic Therapeutics/Drug Revenue by Countries (2015-2020)
Table 86. South America Ophthalmic Therapeutics/Drug Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Ophthalmic Therapeutics/Drug Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Ophthalmic Therapeutics/Drug Revenue Market Share by Countries (2015-2020)
Table 89. Global Ophthalmic Therapeutics/Drug Revenue (Million USD) by Type (2015-2020)
Table 90. Global Ophthalmic Therapeutics/Drug Revenue Share by Type (2015-2020)
Table 91. Global Ophthalmic Therapeutics/Drug Revenue Forecast by Type (2021-2025)
Table 92. Global Ophthalmic Therapeutics/Drug Revenue by Application (2015-2020)
Table 93. Global Ophthalmic Therapeutics/Drug Revenue Share by Application (2015-2020)
Table 94. Global Ophthalmic Therapeutics/Drug Revenue Forecast by Application (2021-2025)
Table 95. Global Ophthalmic Therapeutics/Drug Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Ophthalmic Therapeutics/Drug Picture
Figure 2. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Type in 2019
Figure 3. Anti-allergy Picture
Figure 4. Anti-VEGF Agents Picture
Figure 5. Anti-inflammatory Picture
Figure 6. Anti-glaucoma Picture
Figure 7. Others Picture
Figure 8. Ophthalmic Therapeutics/Drug Revenue Market Share by Application in 2019
Figure 9. Dry Eye Picture
Figure 10. Allergies Picture
Figure 11. Glaucoma Picture
Figure 12. Infection Picture
Figure 13. Retinal Disorders Picture
Figure 14. Uveitis Picture
Figure 15. Others Picture
Figure 16. Global Ophthalmic Therapeutics/Drug Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. North America Ophthalmic Therapeutics/Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Europe Ophthalmic Therapeutics/Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Asia-Pacific Ophthalmic Therapeutics/Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. South America Ophthalmic Therapeutics/Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Middle East and Africa Ophthalmic Therapeutics/Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Ophthalmic Therapeutics/Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Ophthalmic Therapeutics/Drug Revenue Share by Players in 2019
Figure 24. Global Top 5 Players Ophthalmic Therapeutics/Drug Revenue Market Share in 2019
Figure 25. Global Top 10 Players Ophthalmic Therapeutics/Drug Revenue Market Share in 2019
Figure 26. Key Players Market Share Trend
Figure 27. Global Ophthalmic Therapeutics/Drug Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 28. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Regions (2015-2020)
Figure 29. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Regions in 2018
Figure 30. North America Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 31. Europe Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 32. Asia-Pacific Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 33. South America Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 34. Middle East and Africa Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 35. North America Ophthalmic Therapeutics/Drug Revenue Market Share by Countries (2015-2020)
Figure 36. North America Ophthalmic Therapeutics/Drug Revenue Market Share by Countries in 2019
Figure 37. USA Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 38. Canada Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 39. Mexico Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 40. Europe Ophthalmic Therapeutics/Drug Revenue Market Share by Countries (2015-2020)
Figure 41. Europe Ophthalmic Therapeutics/Drug Revenue Market Share by Countries in 2019
Figure 42. Germany Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 43. UK Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 44. France Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 45. Russia Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 46. Italy Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Ophthalmic Therapeutics/Drug Revenue Market Share by Countries (2015-2020)
Figure 48. Asia-Pacific Ophthalmic Therapeutics/Drug Revenue Market Share by Countries in 2019
Figure 49. China Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 50. Japan Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 51. Korea Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 52. India Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 53. Southeast Asia Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 54. South America Ophthalmic Therapeutics/Drug Revenue Market Share by Countries (2015-2020)
Figure 55. South America Ophthalmic Therapeutics/Drug Revenue Market Share by Countries in 2019
Figure 56. Brazil Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 57. Argentina Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 58. Middle East and Africa Ophthalmic Therapeutics/Drug Revenue Market Share by Countries (2015-2020)
Figure 59. Middle East and Africa Ophthalmic Therapeutics/Drug Revenue Market Share by Countries in 2019
Figure 60. Saudi Arabia Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 61. UAE Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 62. Egypt Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 63. South Africa Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2015-2020)
Figure 64. Global Ophthalmic Therapeutics/Drug Revenue Share by Type (2015-2020)
Figure 65. Global Ophthalmic Therapeutics/Drug Revenue Share by Type in 2019
Figure 66. Global Ophthalmic Therapeutics/Drug Market Share Forecast by Type (2021-2025)
Figure 67. Global Anti-allergy Revenue Growth Rate (2015-2020)
Figure 68. Global Anti-VEGF Agents Revenue Growth Rate (2015-2020)
Figure 69. Global Anti-inflammatory Revenue Growth Rate (2015-2020)
Figure 70. Global Anti-glaucoma Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Ophthalmic Therapeutics/Drug Revenue Share by Application (2015-2020)
Figure 73. Global Ophthalmic Therapeutics/Drug Revenue Share by Application in 2019
Figure 74. Global Ophthalmic Therapeutics/Drug Market Share Forecast by Application (2021-2025)
Figure 75. Global Dry Eye Revenue Growth Rate (2015-2020)
Figure 76. Global Allergies Revenue Growth Rate (2015-2020)
Figure 77. Global Glaucoma Revenue Growth Rate (2015-2020)
Figure 78. Global Infection Revenue Growth Rate (2015-2020)
Figure 79. Global Retinal Disorders Revenue Growth Rate (2015-2020)
Figure 80. Global Uveitis Revenue Growth Rate (2015-2020)
Figure 81. Global Others Revenue Growth Rate (2015-2020)
Figure 82. Global Ophthalmic Therapeutics/Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 83. Global Ophthalmic Therapeutics/Drug Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 84. Global Ophthalmic Therapeutics/Drug Revenue Market Share Forecast by Regions (2021-2025)
Figure 85. North America Ophthalmic Therapeutics/Drug Revenue Market Forecast (2021-2025)
Figure 86. Europe Ophthalmic Therapeutics/Drug Revenue Market Forecast (2021-2025)
Figure 87. Asia-Pacific Ophthalmic Therapeutics/Drug Revenue Market Forecast (2021-2025)
Figure 88. South America Ophthalmic Therapeutics/Drug Revenue Market Forecast (2021-2025)
Figure 89. Middle East and Africa Ophthalmic Therapeutics/Drug Revenue Market Forecast (2021-2025)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel




Companies Mentioned
Alcon
Pfizer Inc.
Novartis AG
Johnson and Johnson Vision Care, Inc.
Allergan
Bausch & Lomb Incorporated
Bayer AG
Regeneron Pharmaceuticals Inc.
Merck Sharp & Dohme Corp.
Valeant
Santen Pharmaceuticals Co. Ltd
Genentech, Inc.

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets